Next Century Growth Investors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-24,696
Closed -$3.6M 159
2017
Q3
$3.6M Buy
24,696
+4,947
+25% +$674K 0.43% 72
2017
Q2
$2.56M Buy
19,749
+1,583
+9% +$194K 0.25% 103
2017
Q1
$2.26M Sell
18,166
-1,044
-5% -$125K 0.19% 119
2016
Q4
$2.22M Sell
19,210
-22,408
-54% -$2.5M 0.14% 124
2016
Q3
$4.35M Sell
41,618
-19,667
-32% -$2.13M 0.2% 130
2016
Q2
$6.04M Sell
61,285
-2,129
-3% -$220K 0.28% 96
2016
Q1
$6.35M Buy
63,414
+15,282
+32% +$1.57M 0.3% 98
2015
Q4
$5.76M Sell
48,132
-13
-0% -$1.5K 0.25% 122
2015
Q3
$5.21M Sell
48,145
-15,249
-24% -$1.89M 0.22% 119
2015
Q2
$7.34M Buy
63,394
+16,913
+36% +$1.93M 0.25% 123
2015
Q1
$5.36M Sell
46,481
-1,123
-2% -$134K 0.19% 145
2014
Q4
$5.32M Sell
47,604
-10,377
-18% -$1.09M 0.19% 131
2014
Q3
$5.5M Sell
57,981
-18,069
-24% -$1.63M 0.19% 126
2014
Q2
$6.53M Buy
76,050
+406
+0.5% +$30.9K 0.21% 127
2014
Q1
$5.28M Buy
75,644
+17,882
+31% +$1.42M 0.16% 147
2013
Q4
$4.88M Buy
57,762
+278
+0.5% +$22K 0.14% 155
2013
Q3
$4.42M Sell
57,484
-39,384
-41% -$2.76M 0.13% 153
2013
Q2
$5.66M Buy
+96,868
New +$5.83M 0.18% 126

Other funds holding CELG

Next Century Growth Investors's CELG Position: Q4 2017 in Review

Next Century Growth Investors sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 24,696 shares — an estimated $3.6M sold.

Next Century Growth Investors first reported a position in CELG in Q2 2013 and held it in 18 quarters. The position peaked at $7.34M in Q2 2015. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Next Century Growth Investors reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Next Century Growth Investors sold 24,696 Celgene Corp shares in Q4 2017, an estimated $3.6M.
  • Next Century Growth Investors first reported a position in Celgene Corp in Q2 2013 and held it in 18 quarters.
  • Next Century Growth Investors's Celgene Corp position peaked at $7.34M in Q2 2015.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Next Century Growth Investors's 13F filing for Q4 2017, filed 13 Feb 2018.